RxDoctor Payments Data

William Ante, MD

Physical Medicine & Rehabilitation · Evansville, INNPI 1518964303

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.1% of the total across 225 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by Amgen at 27.9% of the total.

$4,657in general payments, 2019–2025

Across 225 payments — averaging $20.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • Nevro Corp.$746
  • Pacira Therapeutics, Inc.$664
  • Stryker$396
  • Globus Medical$301
  • Medtronic$274
  • plus $978 from 25 others

What the payments were for

  • Travel & lodging$2105%
  • Food & beverage$4,43195%
  • Education$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,657 in reported general payments places this provider in the 85th percentile of 140 physical medicine & rehabilitation providers in Indiana.

See all physical medicine & rehabilitation providers in Indiana

Medicare billing

Part B allowed, 2024
$779,160
Medicare patients
523
Services billed
35,173

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fentanyl65$9,064
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen234$7,463
MovantikNaloxegol Oxalate11$4,593
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen169$3,256
Pregabalin79$2,709
Meloxicam134$2,697
Gabapentin165$2,631
Orphenadrine Citrate ErOrphenadrine Citrate11$1,719
Tramadol Hcl333$1,639
Buprenorphine13$1,101
Celecoxib34$1,059
Duloxetine Hcl39$769
Tizanidine Hcl49$691
Nabumetone43$652
Diclofenac Sodium33$488

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Evansville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →